blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1910573

EP1910573 - METHODS FOR REDUCING VIRAL LOAD IN HIV-1-INFECTED PATIENTS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  11.07.2014
Database last updated on 25.09.2024
Most recent event   Tooltip15.07.2016Lapse of the patent in a contracting state
New state(s): TR		published on 17.08.2016  [2016/33]
Applicant(s)For all designated states
CytoDyn, Inc.
5 Centerpointe Drive, Suite 400
Lake Oswego, OR 97035 / US
[2013/07]
Former [2008/16]For all designated states
PROGENICS PHARMACEUTICALS, INC.
777 Old Saw Mill River Road
Tarrytown, NY 10591 / US
Inventor(s)01 / OLSON, William, C.
21 Fawn Court
Ossining, NY 10562 / US
02 / MADDON, Paul, J.
191 Fox Meadow Road
Scarsdale, NY 10583 / US
03 / PEVEAR, Daniel, C.
256 Morris Road
Harleysville, PA 19438 / US
04 / ISRAEL, Robert, J.
50 Oxford Drive
Suffern, NY 10901 / US
05 / MURGA, Jose, D.
244-12 137th Road
Rosedale, NY 11422 / US
 [2008/16]
Representative(s)Almond-Martin, Carol, et al
Ernest Gutmann - Yves Plasseraud S.A.S. 88, Boulevard des Belges
69452 Lyon Cedex 06 / FR
[2013/36]
Former [2008/16]Almond-Martin, Carol, et al
ERNEST GUTMANN - YVES PLASSERAUD S.A.S. 88, Boulevard des Belges
69452 Lyon Cedex 06 / FR
Application number, filing date06788240.721.07.2006
[2008/16]
WO2006US28565
Priority number, dateUS20050701889P23.07.2005         Original published format: US 701889 P
US20050702064P22.07.2005         Original published format: US 702064 P
US20050711528P26.08.2005         Original published format: US 711528 P
US20050715619P09.09.2005         Original published format: US 715619 P
[2008/16]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2007014114
Date:01.02.2007
Language:EN
[2007/05]
Type: A2 Application without search report 
No.:EP1910573
Date:16.04.2008
Language:EN
The application published by WIPO in one of the EPO official languages on 01.02.2007 takes the place of the publication of the European patent application.
[2008/16]
Type: B1 Patent specification 
No.:EP1910573
Date:04.09.2013
Language:EN
[2013/36]
Search report(s)International search report - published on:US08.01.2009
(Supplementary) European search report - dispatched on:EP04.03.2010
ClassificationIPC:C07K16/28, A61K39/395, A61K39/42
[2013/12]
CPC:
A61K31/351 (EP,US); A61K39/395 (KR); A61K39/39 (US);
A61K31/4178 (EP,US); A61K31/46 (EP,US); A61K31/496 (EP,US);
A61K31/506 (EP,US); A61K31/551 (EP,US); A61K31/7072 (EP,US);
A61K38/1709 (US); A61K38/195 (US); A61K39/39541 (EP,US);
A61K39/3955 (US); A61P31/18 (EP); A61P43/00 (EP);
C07K16/2866 (EP,US); C12Q1/701 (EP,US); A61K2039/505 (US);
A61K2039/55511 (US); C07K2317/24 (EP,US); C07K2317/76 (EP,US) (-)
C-Set:
A61K39/39541, A61K2300/00 (EP,US)
Former IPC [2009/11]A61K39/42, C07K16/00, A01N61/00
Former IPC [2008/16]C12Q1/68, G01N33/53
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/16]
Extension statesAL21.02.2008
BA21.02.2008
HR21.02.2008
MK21.02.2008
RS21.02.2008
TitleGerman:VERFAHREN ZUR REDUZIERUNG DER VIRUSLAST IN MIT HIV-1 INFIZIERTEN PATIENTEN[2008/17]
English:METHODS FOR REDUCING VIRAL LOAD IN HIV-1-INFECTED PATIENTS[2008/16]
French:PROCÉDÉS POUR LA RÉDUCTION DE LA CHARGE VIRALE CHEZ DES PATIENTS INFECTÉS PAR LE VIH 1[2008/16]
Former [2008/16]VERFAHREN ZUR REDUZIERUNG DER VIRUSLAST IN MIT HIV-1INFIZIERTEN PATIENTEN
Biological materialThis application mentions deposited biological material, check the file for details
Entry into regional phase21.02.2008National basic fee paid 
21.02.2008Search fee paid 
21.02.2008Designation fee(s) paid 
21.02.2008Examination fee paid 
Examination procedure14.02.2007Request for preliminary examination filed
International Preliminary Examining Authority: US
21.02.2008Examination requested  [2008/16]
10.06.2010Amendment by applicant (claims and/or description)
01.09.2010Despatch of a communication from the examining division (Time limit: M06)
11.03.2011Reply to a communication from the examining division
10.10.2012Cancellation of oral proceeding that was planned for 27.11.2012
27.11.2012Date of oral proceedings (cancelled)
31.01.2013Cancellation of oral proceeding that was planned for 05.02.2013
05.02.2013Date of oral proceedings (cancelled)
08.03.2013Communication of intention to grant the patent
05.07.2013Fee for grant paid
05.07.2013Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  01.09.2010
Opposition(s)05.06.2014No opposition filed within time limit [2014/33]
Fees paidRenewal fee
18.06.2008Renewal fee patent year 03
20.07.2009Renewal fee patent year 04
27.07.2010Renewal fee patent year 05
29.07.2011Renewal fee patent year 06
30.01.2013Renewal fee patent year 07
29.07.2013Renewal fee patent year 08
Penalty fee
Additional fee for renewal fee
31.07.201207   M06   Fee paid on   30.01.2013
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU21.07.2006
AT04.09.2013
BE04.09.2013
BG04.09.2013
CY04.09.2013
CZ04.09.2013
DK04.09.2013
EE04.09.2013
FI04.09.2013
LT04.09.2013
LV04.09.2013
MC04.09.2013
PL04.09.2013
RO04.09.2013
SE04.09.2013
SI04.09.2013
SK04.09.2013
TR04.09.2013
GR05.12.2013
IS04.01.2014
PT06.01.2014
[2016/33]
Former [2016/32]HU21.07.2006
AT04.09.2013
BE04.09.2013
BG04.09.2013
CY04.09.2013
CZ04.09.2013
DK04.09.2013
EE04.09.2013
FI04.09.2013
LT04.09.2013
LV04.09.2013
MC04.09.2013
PL04.09.2013
RO04.09.2013
SE04.09.2013
SI04.09.2013
SK04.09.2013
GR05.12.2013
IS04.01.2014
PT06.01.2014
Former [2016/25]AT04.09.2013
BE04.09.2013
BG04.09.2013
CY04.09.2013
CZ04.09.2013
DK04.09.2013
EE04.09.2013
FI04.09.2013
LT04.09.2013
LV04.09.2013
MC04.09.2013
PL04.09.2013
RO04.09.2013
SE04.09.2013
SI04.09.2013
SK04.09.2013
GR05.12.2013
IS04.01.2014
PT06.01.2014
Former [2016/21]AT04.09.2013
BE04.09.2013
CY04.09.2013
CZ04.09.2013
DK04.09.2013
EE04.09.2013
FI04.09.2013
LT04.09.2013
LV04.09.2013
MC04.09.2013
PL04.09.2013
RO04.09.2013
SE04.09.2013
SI04.09.2013
SK04.09.2013
GR05.12.2013
IS04.01.2014
PT06.01.2014
Former [2014/41]AT04.09.2013
BE04.09.2013
CY04.09.2013
CZ04.09.2013
DK04.09.2013
EE04.09.2013
FI04.09.2013
LT04.09.2013
LV04.09.2013
PL04.09.2013
RO04.09.2013
SE04.09.2013
SI04.09.2013
SK04.09.2013
GR05.12.2013
IS04.01.2014
PT06.01.2014
Former [2014/28]AT04.09.2013
BE04.09.2013
CY04.09.2013
CZ04.09.2013
EE04.09.2013
FI04.09.2013
LT04.09.2013
LV04.09.2013
PL04.09.2013
RO04.09.2013
SE04.09.2013
SI04.09.2013
SK04.09.2013
GR05.12.2013
IS04.01.2014
PT06.01.2014
Former [2014/23]AT04.09.2013
BE04.09.2013
CY04.09.2013
CZ04.09.2013
EE04.09.2013
FI04.09.2013
LT04.09.2013
LV04.09.2013
PL04.09.2013
RO04.09.2013
SE04.09.2013
SI04.09.2013
SK04.09.2013
GR05.12.2013
IS04.01.2014
Former [2014/22]AT04.09.2013
BE04.09.2013
CY04.09.2013
FI04.09.2013
LT04.09.2013
LV04.09.2013
PL04.09.2013
RO04.09.2013
SE04.09.2013
SI04.09.2013
GR05.12.2013
Former [2014/18]AT04.09.2013
BE04.09.2013
CY04.09.2013
FI04.09.2013
LT04.09.2013
LV04.09.2013
PL04.09.2013
SE04.09.2013
SI04.09.2013
GR05.12.2013
Former [2014/12]CY03.07.2013
AT04.09.2013
FI04.09.2013
LT04.09.2013
LV04.09.2013
PL04.09.2013
SE04.09.2013
SI04.09.2013
GR05.12.2013
Former [2014/11]CY03.07.2013
AT04.09.2013
FI04.09.2013
LT04.09.2013
PL04.09.2013
SE04.09.2013
Former [2014/10]CY03.07.2013
AT04.09.2013
LT04.09.2013
SE04.09.2013
Former [2014/09]AT04.09.2013
LT04.09.2013
SE04.09.2013
Former [2014/08]LT04.09.2013
Documents cited:Search[XY]WO03072766  (PROGENICS PHARM INC [US], et al) [X] 22-23,25-28,31,38 * pg. 4 pg. 30, sec. paragraph pg. 44, sec. paragraph * [Y] 1-21,29-30,32-37;
 [Y]  - Genentech, "Herceptin / Trastuzumab", (2003), URL: http://www.cancerconsultants.com/druginserts/trastuzumab.pdf', (20100211), XP007911675 [Y] 1-21,23,25-38 * first page *
 [Y]  - MAEDA KENJI ET AL, "Spirodiketopiperazine-based CCR5 inhibitor which preserves CC-chemokine/CCR5 interactions and exerts potent activity against R5 human immunodeficiency virus type 1 in vitro.", JOURNAL OF VIROLOGY AUG 2004, (200408), vol. 78, no. 16, ISSN 0022-538X, pages 8654 - 8662, XP002568117 [Y] 32-34 * abstract *

DOI:   http://dx.doi.org/10.1128/JVI.78.16.8654-8662.2004
 [XY]  - OLSON W C ET AL, "Resistance to HIV-1 entry inhibitors.", CURRENT DRUG TARGETS - INFECTIOUS DISORDERS, (200312), vol. 3, no. 4, ISSN 1568-0053, pages 283 - 294, XP009129415 [X] 22,24 * 287-289 * [Y] 1-21,23,25-38
 [XY]  - OLSON W C ET AL, "DIFFERENTIAL INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 FUSION, GP120 BINDING, AND CC-CHEMOKINE ACTIVITY BY MONOCLONAL ANTIBODIES TO CCR5", JOURNAL OF VIROLOGY, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, (19990501), vol. 73, no. 5, ISSN 0022-538X, pages 4145 - 4155, XP009129481 [X] 22,24 * abstract * [Y] 1-21,23,25-38
 [A]  - POLI G, "PRO-140 (Progenics)", IDRUGS, CURRENT DRUGS LTD, GB, (20010901), vol. 4, no. 9, ISSN 1369-7056, pages 1068 - 1071, XP009129422 [A] 1-38 * the whole document *
 [A]  - KETAS T J ET AL, "Human immunodeficiency virus type 1 attachment, coreceptor, and fusion inhibitors are active against both direct and trans infection of primary cells", JOURNAL OF VIROLOGY, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, (20030201), vol. 77, no. 4, ISSN 0022-538X, pages 2762 - 2767, XP002404182 [A] 1-38 * abstract *

DOI:   http://dx.doi.org/10.1128/JVI.77.4.2762-2767.2003
International search[Y]US2002146415  (OLSON WILLIAM C [US], et al);
 [Y]US2002177603  (JOHNSON BARRY L [DE], et al);
 [Y]US2003228306  (OLSON WILLIAM C [US], et al);
 [Y]US2005131042  (FLENTGE CHARLES A [US], et al)
ExaminationWO2008134076
by applicantWO0162255
 WO03082289
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.